세계의 임신 준비 영양제 시장 : 인사이트, 경쟁 구도 및 시장 예측(2030년)

Fertility Supplements Market By Ingredient Type (Natural, Synthetic/Blend Of Sythetic And Natural), Type (Capsules, Tablets, Soft Gels, Powder, And Liquid) End-User (Men And Women), Distribution Channel (Retail Pharmacy, Online Pharmacy And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of infertility and the growing awareness on reproductive health

The global fertility supplements market was valued at USD 1,929.22 million in 2022 and is likely to register a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2,983.27 million by 2030. The demand for fertility supplements is primarily being boosted owing to key factors such as the increasing number of cases of infertility, rise in risk factors associated with causing infertility, growing awareness on reproductive health coupled with increasing product launches thereby creating a positive market growth for fertility supplements during the forecast period from 2024-2030.

Fertility Supplements Market Dynamics:

One of the key factors influencing the growth of the fertility supplements market is the rising prevalence of infertility along with its risk factors among individuals in the reproductive age group. Infertility affects a significant percentage of couples worldwide, and the desire to conceive has fueled the demand for fertility-related products and services.

The data published by Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.

As per the above mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having TFR of 1.58, Canada 1.50, China 1.70, United States 1.64, United Kingdom 1.56, Spain 1.36, Japan 1.33, and South Korea with 0.84 TFR.

The World Health Organization (WHO) 2023 estimates suggests that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.

According to World Bank 2022, the total fertility rate (TFR) in most of the regions including North and South America to Europe and Asia-Pacific was 1.6 in 2020 which is comparatively lower than the average TFR of 2.1.

As people face difficulties in conceiving naturally, they often turn to fertility supplements as a potential solution. In addition, several factors contribute to the rising infertility rates, including lifestyle changes, delayed pregnancies due to career pursuits, environmental factors, alcohol consumption, smoking, lack of physical activity, and obesity among others.

According to Centers for Disease Control and Prevention (CDC) 2022 , in 2020, nearly 13 of every 100 US adults aged 18 years or older smoked cigarettes. As per the data reported by Foundation for a Smoke-Free World 2022, there were 20.4 million adult smokers in Brazil in 2019. Smoking is one of the major factor responsible for causing infertility in both men and women. It not only affects semen quality in males but also creates complications for women who wish to conceive.

Obesity which is largely associated with causing reproductive disorders, particularly in women is on rise. It is associated with anovulation, menstrual disorders, infertility, difficulties in assisted reproduction, miscarriage, and adverse pregnancy outcomes.

As per OECD Health Statistics 2021, about 33% of women population of Switzerland, 38.4% in Italy, and 42.7% women in Spain were overweight including obesity in 2019.

Thus, the increasing incidences of infertility among men and women are increasing the demand for fertility supplements, which is anticipated to boost the market's growth over the forecast period from 2024-2030.

However, lack of regulatory oversight and standardization, availability of alternative options in the market such as in-vitro fertilization may restrict the growth of the fertility supplements market.

Fertility Supplements Market Segment Analysis:

Fertility Supplements Market by Ingredient Type (Natural, Synthetic/Blend of Synthetic and Natural), Type (Capsules, Tablets, Soft Gels, Powder and Liquid), End-User (Men and Women), Distribution Channel (Retail Pharmacy, Online Pharmacy, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the end-user segment of the fertility supplements market, women are expected to hold the largest share of 59.56% in the year 2023. This can be attributed to the growing risk of female infertility and role of fertility supplements in effective cure and management of female infertility which will be responsible for the increased demand of fertility supplements during the given forecast period.

The factors such as age, hormonal imbalances, weight, exposure to chemicals or radiation, and cigarette smoking contribute in female infertility. The female reproductive system disorders such as cervical mucus issues, endometriosis, damage to the fallopian tubes, polycystic ovary syndrome, (pcos), and uterine fibroids among others may also hinder the ability of women to conceive.

According to World Health Organization (WHO) 2021, roughly around 190 million (10%) women and girls of reproductive age get affected by endometriosis. As per OECD Health Statistics 2021, nearly more than 20% of the women population in countries like Hungary, Chile and France were involved in daily smoking in 2019. As per the same source 5% of women smoked daily in Indonesia, India, China, Costa Rica, Mexico and Korea in 2019. Smoking affects the female reproductive system and makes it difficult for women to conceive. Fertility supplements are crucial for the reproductive health of women. In order to produce the ideal conditions for a successful pregnancy, the intake of appropriate fertility supplements having composition of vitamin and mineral and other useful ingredients is essential.

The female fertility supplements may even help to lessen PCOS symptoms, a major underlying cause of infertility. PROFERTIL® female by LENUS Pharma GesmbH is female fertility supplement that increases the chance of having a baby. Also, the females prefer fertility supplements rather than visiting the doctor and opting for heavy dose of medicines.

Thus, the interplay of the above factors is expected to drive the growth of women category, thereby propelling the overall growth of fertility supplements market during the forecast period from 2023-2028.

North America is expected to dominate the overall Fertility Supplements Market:

Among all the regions, North America is expected to hold the largest share of 40.10% in the fertility supplements market in 2022. Some of the factors responsible for the growth of North America's fertility supplements market are the increasing prevalence of infertility in the region, increasing awareness for fertility supplements, and the presence of major players. Furthermore, increasing healthcare expenditure, rising research and development activities in the region associated with the surging launch of natural fertility supplements is also driving the market growth of fertility supplements in North America.

As per the data provided by the Centers for Disease Control and Prevention (CDC) 2023, in the United States, among married women aged 15 to 49 years with no prior births, about 1 in 5 (19%) are unable to get pregnant after one year of trying (infertility). Also, about 1 in 4 (26%) women have difficulty getting pregnant or carrying a pregnancy to term (impaired fecundity). About 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term. In countries such as Canada, the fertility cases are quiet low. As per the Statistics Canada 2022, country's fertility rate decreased from 1.47 children per woman in 2019 to a record low of 1.40 children per woman in 2020.

Thus, the increasing infertility rate in the US and Canada will increase the demand for fertility supplements as these supplements aid in providing optimum amount of vitamins and hormones required for fertility in the body. Therefore, due to increase in the demand for fertility supplements in the region, there will subsequent rise in the growth of the North America fertility supplements market during the forecast period.

Fertility Supplements Market Key Players:

Some of the key market players operating in the Fertility Supplements market include Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Insud Pharma, Ovaterra, Vitabiotics Ltd, Orthomol Pharmazeutische Vertriebs GmbH, Snowden Healthcare, Crown Fertility, YadTech, Affirm Health Ltd., BabyRx, Anglo-French Drugs & Industries Ltd., Pillar Healthcare, Nua Fertility, Laboratories Fertypharm S.L., Zacina, SAMSAR PHARMACEUTICALS SPRL, AdvaCare Pharma, and others.

Recent Developmental Activities in the Fertility Supplements Market:

In November 2022, AFD Pharma entered the fertility space in India with its Lyber range. The Lyber range includes 3 products namely, LYBER-M - a male fertility supplement; LYBER-PCO - a PCOS treatment drug and LYBER+ which is an herbal formulation of Shilajit and other power-packed phytomedicines which increases stamina, strength, energy and relieves stress.

In June 2022, the Natalist Company launched new products such as fertility supplements for every stage of the reproductive journey. The company launched consumer fertility, pregnancy, and essential postpartum products around 100% plastic neutral, including CoQ10 gummies, prenatal gummies, and other fertility and pregnancy test products.

In April 2022, the leading market player, Ovaterra, launched two prenatal vitamin supplement products, Advanced Prep 35-39 & Advanced Prenatal, designed for pre, during, and post-pregnancy care.

Key Takeaways from the Fertility Supplements Market Report Study

Market size analysis for current Fertility Supplements market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Fertility Supplements market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global Fertility Supplements market.

Various opportunities available for the other competitor in the Fertility Supplements market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current Fertility Supplements market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Fertility Supplements Market growth in the coming future?

Target Audience who can be benefited from this Fertility Supplements Market Report Study

Fertility Supplements products providers

Research organizations and consulting companies

Fertility Supplements-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Fertility Supplements

Various End-users who want to know more about the Fertility Supplements market and the latest technological developments in the Fertility Supplements market.

Frequently Asked Questions for the Fertility Supplements Market:

1. What are Fertility Supplements?

Fertility Supplements are dietary supplements designed to support reproductive health and improve fertility in both men and women. They are usually in the form of pills, capsules, soft gels, or liquid dietary supplements that are sold over the counter without a prescription and contain specific nutrients designed to support the quality of eggs, sperm, or other aspects of reproductive health.

2. What is the market for global Fertility Supplements?

The global fertility supplements market was valued at USD 1,929.22 million in 2022 and is likely to register a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2,983.27 million by 2030.

3. What are the drivers for the global Fertility Supplements market?

The demand for fertility supplements is primarily being boosted owing to key factors such as the increasing number of cases of infertility, rise in risk factors associated with causing infertility, growing awareness on reproductive health coupled with increasing product launches thereby creating a positive market growth for fertility supplements during the forecast period from 2024-2030.

4. Who are the key players operating in the global Fertility Supplements market?

Some of the key market players operating in the Fertility Supplements market include Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Insud Pharma, Ovaterra, Vitabiotics Ltd, Orthomol Pharmazeutische Vertriebs GmbH, Snowden Healthcare, Crown Fertility, YadTech, Affirm Health Ltd., BabyRx, Anglo-French Drugs & Industries Ltd., Pillar Healthcare, Nua Fertility, Laboratories Fertypharm S.L., Zacina, SAMSAR PHARMACEUTICALS SPRL, AdvaCare Pharma, and others.

5. Which region has the highest share in the Fertility Supplements market?

North America is expected to dominate the overall Fertility Supplements market during the forecast period from 2024-2030. Owing to factors such as the increasing prevalence of infertility in the region, increasing awareness for fertility supplements, and the presence of major players are expected to drive the demand for fertility supplements. Furthermore, increasing healthcare expenditure, rising research and development activities in the region associated with the surging launch of natural fertility supplements is also driving the market growth of fertility supplements in North America.

Table of Contents

1.Fertility Supplements Market Report Introduction

2. Fertility Supplements Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Fertility Supplements Market Key Factors Analysis

• 4.1. Fertility Supplements Market Drivers
  • 4.1.1. Rising prevalence of infertility and its risk factors
  • 4.1.2. Rising awareness and focus on reproductive health
  • 4.1.3. Increased adoption of natural and holistic approaches
• 4.2. Fertility Supplements Market Restraints and Challenges
  • 4.2.1. Lack of regulatory oversight and standardization
  • 4.2.2. Alternative options available in the market such as In-Vitro Fertilization (IVF)
• 4.3. Fertility Supplements Market Opportunities
  • 4.3.1. Increasing Lucrative opportunities in the emerging markets and global expansion

5. Fertility Supplements Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Fertility Supplements Market Layout

• 6.1. By Ingredient Type
  • 6.1.1. Natural
  • 6.1.2. Synthetic/Blend of Natural and Synthetic
• 6.2. By Type
  • 6.2.1. Capsules
  • 6.2.2. Tablets
  • 6.2.3. Soft Gels
  • 6.2.4. Powder
  • 6.2.5. Liquid
• 6.3. By End-User
  • 6.3.1. Men
  • 6.3.2. Women
• 6.4. By Distribution Channel
  • 6.4.1. Retail Pharmacy
  • 6.4.2. Online Pharmacy
  • 6.4.3. Others
• 6.5. By Geography
  • 6.5.1. North America Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.1.1. United States Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.1.2. Canada Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.1.3. Mexico Fertility Supplements Market Size in USD million (2021-2030)
  • 6.5.2. Europe Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.1. France Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.2. Germany Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.3. United Kingdom Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.4. Italy Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.5. Spain Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2.6. Rest of Europe Fertility Supplements Market Size in USD million (2021-2030)
  • 6.5.3. Asia-Pacific Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.1. China Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.2. Japan Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.3. India Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.4. Australia Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.5. South Korea Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3.6. Rest of Asia-Pacific Fertility Supplements Market Size in USD million (2021-2030)
  • 6.5.4. Rest of the World (RoW) Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.4.1. Middle East Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.4.2. Africa Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.4.3. South America Fertility Supplements Market Size in USD million (2021-2030)

7. Fertility Supplements Market Company and Product Profiles

• 7.1. Fairhaven Health
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Coast Science
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. LENUS Pharma GesmbH
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Active Bio Life Science GmbH
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Insud Pharma
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Ovaterra
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Vitabiotics Ltd
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Orthomol Pharmazeutische Vertriebs GmbH
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Snowden Healthcare
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Crown Fertility
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. YadTech
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Affirm Health Ltd.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. BabyRx
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Anglo-French Drugs & Industries Ltd.
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Pillar Healthcare
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Nua Fertility
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. Laboratories Fertypharm S.L.
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. Zacina
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. SAMSAR PHARMACEUTICALS SPRL
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. AdvaCare Pharma
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us